No abstract

fMRI research suggests that both the posterior parietal cortex (PPC) and dorsolateral prefrontal cortex (DLPFC) help individuals select better long-term monetary gains during intertemporal choice. Previous neuromodulation research has demonstrated that disruption of the DLPFC interferes with this ability. However, it is unclear whether the PPC performs a similarly important function during intertemporal choice, and whether the functions performed by either region impact choices involving losses. In the current study, we used low-frequency repetitive transcranial magnetic stimulation to examine whether the PPC and DLPFC both normally facilitate selection of gains and losses with better long-term value than alternatives during intertemporal choice. We found that disruption of either region in the right hemisphere led to greater selection of both gains and losses that had better immediate, but worse long-term value than alternatives. This indicates that activity in both regions helps individuals optimize long-term value relative to immediate value in general, rather than being specific to choices involving gains. However, there were slightly different patterns of effects following disruption of the right PPC and right DLPFC, suggesting that each region may perform somewhat different functions that help optimize choice.

Using a monoclonal antibody that is specific for type IV collagen we have examined examples of actinically damaged skin, intraepithelial carcinomas and squamous cell carcinomas of varying degrees of differentiation for abnormalities in the basement membrane. In examples of intraepithelial carcinoma and the occasional early invasive carcinoma a residual type IV collagen framework is suggestive of tumour regression. Production of type IV collagen by some tumours supports the view that squamous cell carcinomas do not apparently require to destroy this basement membrane component in order to invade or to metastasize.

Thymidylate synthase (TYMS; EC 2.1.1.15) catalyzes the reductive methylation of 2ʹ-deoxyuridine-5ʹ-monophosphate (dUMP) by N 5 ,N 10 -methyhlenetetrahydrofolate, forming dTMP for the maintenance of DNA replication and repair. Inhibitors of TYMS have been widely used in the treatment of neoplastic disease. A number of fluoropyrimidine and folate analogs have been developed that lead to inhibition of the enzyme, resulting in dTMP deficiency and cell death. In the current study, we have examined the role of oxidative stress in response to TYMS inhibitors. We observed that intracellular reactive oxygen species (ROS) concentrations are induced by these inhibitors and promote apoptosis. Activation of the enzyme NADPH oxidase (NOX), which catalyzes one-electron reduction of O 2 to generate superoxide (O 2 d2 ), is a significant source of increased ROS levels in drug-treated cells. However, gene expression profiling revealed a number of other redox-related genes that may contribute to ROS generation. TYMS inhibitors also induce a protective response, including activation of the transcription factor nuclear factor E2-related factor 2 (NRF2), a critical mediator of defense against oxidative and electrophilic stress. Our results show that exposure to TYMS inhibitors induces oxidative stress that leads to cell death, while simultaneously generating a protective response that may underlie resistance against such death.

A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children A comparative study of immunohistochemical staining for neuron-specific enolase (NSE), protein-gene product 9.5 (PGP 9.5) and S-100 was made in 71 undifferentiated round cell tumours from 65 children using formalin-fixed tissues and a standard alkaline phosphatase-anti-alkaline phosphatase method. All of 29 neuroblastomas marked for NSE and 2 7 for PGP 9.5; staining was diffuse and usually strong in all tumour elements, irrespective of the degree of differentiation. Patterns of staining remained consistent in primary, recurrent and metastatic tumours and were not modified by previous chemotherapy. S-1 00 staining was weak and confined to cell processes and schwannian elements in less than half of the tumours studied. Two primitive neuroectoderma1 tumours both stained strongly for NSE and PGP 9.5. Staining for NSE was observed in single maturing cells in 3/12 rhabdomyosarcomas and in tubular elements in 2/ 4 Wilms' tumours: primitive rhabdomyoblasts and undifferentiated renal blastema were negative: seven lymphomas were negative. Six of 1 7 skeletal Ewing's sarcomas showed light to moderate cytoplasmic staining for NSE and PGP 9.5. The site, histology and clinical course of these marker-positive Ewing's sarcomas showed no distinctive features. Staining for PGP 9.5 is a useful additional marker for neural differentiation in round cell tumours.